Does RUCAPARIB CAMSYLATE Cause Off label use? 248 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 248 reports of Off label use have been filed in association with RUCAPARIB CAMSYLATE (Rubraca). This represents 3.0% of all adverse event reports for RUCAPARIB CAMSYLATE.
248
Reports of Off label use with RUCAPARIB CAMSYLATE
3.0%
of all RUCAPARIB CAMSYLATE reports
23
Deaths
41
Hospitalizations
How Dangerous Is Off label use From RUCAPARIB CAMSYLATE?
Of the 248 reports, 23 (9.3%) resulted in death, 41 (16.5%) required hospitalization, and 1 (0.4%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUCAPARIB CAMSYLATE. However, 248 reports have been filed with the FAERS database.
What Other Side Effects Does RUCAPARIB CAMSYLATE Cause?
Fatigue (2,494)
Nausea (2,219)
Malignant neoplasm progression (1,162)
Decreased appetite (787)
Constipation (763)
Diarrhoea (759)
Vomiting (759)
Asthenia (660)
Adverse event (571)
Carbohydrate antigen 125 increased (562)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which RUCAPARIB CAMSYLATE Alternatives Have Lower Off label use Risk?
RUCAPARIB CAMSYLATE vs RUFINAMIDE
RUCAPARIB CAMSYLATE vs RUPATADINE
RUCAPARIB CAMSYLATE vs RUXOLITINIB
RUCAPARIB CAMSYLATE vs SABRIL
RUCAPARIB CAMSYLATE vs SACCHAROMYCES CEREVISIAE